Kamoun, M., Kadin, M.E., Martin, P.J., Nettleton, J., and Hansen, J.A. 1981. A novel T cell antigen preferentially expressed on mature T cells and shared by both well and poorly differentiated B cell leukemias and lymphomas. J. Immunol. 127:987-991.
Krensky, A.M., Sanchez-Madrid, F., Robbins, E., Nagy, J.A., Springer, T.A., and Burakoff, S.J.
1983. The functional significance, distribution and structure of LFA-1, LFA-2 and LFA-3: Cell surface antigens associated with CTL target interactions. J. Immunol. 131:611-616.
Lay, W.H., Mendes, N.F., Bianco, C., and Nussen-zweig, V. 1971. Binding of sheep red blood cells to a large population of human lymphocytes. Nature 230:531-533.
Levine, S. 1956. Magnetic techniques for in vitro isolation of leucocytes. Science 123:185-186.
Loken, M., Shah, V., Dattilio, K., and Civin, C. 1987. Flow cytometric analysis of human bone marrow: II. Normal B cell development. Blood 70:1316-1324.
Ly, A. and Mishell, R.I. 1974. Separation of mouse spleen cells by passage through columns of Sephadex G-10. J. Immunol. Methods 5:239247.
Meuer, S.C., Hussey, R.E., Fabbi, M., Fox, D., Or-este, A., Fitzgerald, K.A., Hodgdon, J.C., Proten-tis, J.P., Schlossman, S.F., and Reinherz, E.L.
1984. An alternate pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein. Cell 36:897-906.
Monroe, J.G. and Seyfert, V.L. 1988. Studies of surface immunoglobulin-dependent B cell activation. Immunol. Res. 7:136-151.
Muraguchi, A., Butler, J., Kehrl, J., and Fauci, A. 1983. Differential sensitivity of human B cell subsets to activation signals delivered by anti-|l antibody and proliferative signal delivered by a monoclonal B cell growth factor. J. Exp. Med. 157:530-546.
Nadler, L., Anderson, K., Marti, G., Bates, M., Park, E., Daley, J., and Schlossman, S. 1983. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J. Immunol. 131:244250.
O'Rourke, E.J., Halstead, S.B., Allison, A.C., and Platts-Mills, T.A.E. 1978. Specific lethality of silica for human peripheral blood mononuclear phagocytes, in vitro. J. Immunol. Methods 19:137-151.
Pezzutto, A., Dorken, B., Rabinovitch, P., Ledbetter, J., Moldenhauer, G., and Clark, E. 1987. CD19 monoclonal antibody HD37 inhibits anti-immu-noglobulin-induced B cell activation and proliferation. J. Immunol. 138:2793-2799.
Phillips, N.E. and Parker, D.C. 1984. Cross-linking of B lymphocyte Fc-y receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis. J. Immunol. 132:627632.
Preud'homme, J.-L. and Flandrin, G. 1974. Identification by peroxidase staining of monocytes in surface immunofluorescence tests. J. Immunol. 113:1650-1653.
Rabinovitch, M. and De Stefano, M.J. 1973. Macrophage spreading in vitro. Exp. Cell Res. 77:323334.
Rasmussen, A.-M., Smeland, E.B., Erikstein, B.K., Caignault, L., and Funderud, S. 1992. A new method for detachment of Dynabeads from positively selected B lymphocytes. J. Immunol. Methods 146:195-202.
Reinhertz, E.L. and Schlossman, S.F. 1982. Human T lymphocyte differentiation. Immunol. Today 3:16-17.
Ryan, J.L. and Henkart, P.A. 1976. Fc receptor-mediated inhibition of murine B-lymphocyte activation. J. Exp. Med. 144:768-775.
Selvaraj, P., Plunkett, M.L., Dustin, M., Sanders, M.E., Shaw, S., and Springer, T.A. 1987. The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3.Nature 326:400-403.
Stashenko, P., Nadler, L.M., Hardy, R., and Schlossman, S.F. 1980. Characterization of a human B lymphocyte-specific antigen. J. Immunol. 125:1678-1685.
Tebbi, K. 1973. Purification of lymphocytes. Lancet 1:1392.
Thiele, D.L. and Lipsky, P.E. 1982. The accessory function of phagocytic cells in human T cell and B cell responses. J. Immunol. 129:1033-1040.
Thiele, D.L. and Lipsky, P.E. 1985. Modulation of human natural killer cell function by L-leucine methyl ester: Monocyte-dependent depletion from human peripheral blood mononuclear cells. J. Immunol. 134:786-793.
Thiele, D.L. and Lipsky, P.E. 1986. The immunosuppressive activity of L-leucyl-L-leucine methyl ester: Selective ablation of cytotoxic lymphocytes and monocytes. J. Immunol. 136:10381048.
Thiele, D.L. and Lipsky, P.E. 1990. Mechanism of L-leucyl-L-leucine methyl ester-mediated killing of cytotoxic lymphocytes: Dependence on a lysosomal thiol protease, dipeptidyl peptidase I, that is enriched in these cells. Proc. Natl. Acad. Sci. U.S.A. 87:83-87.
Thiele, D., Kurosaka, M., and Lipsky, P. 1983. Phe-notype of the accessory cells necessary for mito-gen-stimulated T and B cell responses in human peripheral blood: Delineation by its sensitivity to the lysosomotrophic agent, L-leucine methyl ester. J. Immunol. 131:2282-2290.
Thompson, C.B., Scher, M., Schaefer, M., Lindsten, T., Finkelman, F., and Mond, J. 1984. Size-dependent B lymphocyte subpopulations: Relationship of cell volume to surface phenotype, cell cycle, proliferative response, and requirements for antibody production to TNP-Ficoll and TNP-BA. J. Immunol. 133:2333-2342.
Thompson, P.A., Jelinek, D.F., and Lipsky, P.E. 1984. Regulation of human B cell proliferation by prostaglandin E2. J. Immunol. 133:24462452.
Trizio, D. and Cudkowicz, G. 1974. Separation of T and B lymphocytes by nylon wool columns: Evaluation of efficacy by functional assays in vivo. J. Immunol. 113:1093-1097.
Thompson et al., 1984. See above.
Details the purification procedure outlined here and describes the functional properties of purified B cells.
Contributed by Judy B. Splawski and Peter E. Lipsky The Harold C. Simmons Arthritis Research
Center and University of Texas Southwestern Medical Center Dallas, Texas
Eli M. Eisenstein (positive selection) Hadassah Medical Organization Jerusalem, Israel
Kevin S. Chua (positive selection) National Institute of Allergy and
Infectious Diseases Bethesda, Maryland
Immunologic Studies in Humans
Was this article helpful?